This post was also written by Christine Liu and Gordon Schatz.

China’s Ministry of Health, along with five other government agencies, issued Trial Regulations on Centralized Procurement of High-Value Consumable Medical Supplies on December 17, 2012. These regulations went into effect immediately upon issuance and contain procedures for the centralized purchasing of a wide range of medical devices. Of particular note are the provisions addressing misconduct, which impose potentially significant penalties for commercial bribery and other misconduct.

Please click here to read the issued Client Alert.